You do not cut out animal research but you push for a clearer path to safely start research in humans. Instead of repeated and overlapping pre-clinical studies, focus on designing studies to move as rapidly into humans as possible while retaining a reasonable risk profile. The longer people do work on animals the more they optimize for and are invested in the animal solution.